Combination therapy of high-intensity dose rosuvastatin and ezetimibe: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

3

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Not applicable 1

Conditions being studied

Condition	Trials
High cholesterol	1
Peripheral Artery Disease	1
Polyvascular Disease	1

Recruiting trials involving Combination therapy of high-intensity dose rosuvastatin and ezetimibe

Randomized Comparison of Efficacy and Safety of High-intensity Rosuvastatin/Ezetimibe Combination Versus Treat-to-target Rosuvastatin Monotherapy for Patients With Peripheral Artery or Polyvascular Disease (CARE-PVD Trial)
NCT06231966 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years to 80 Years · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Combination therapy of high-intensity dose rosuvastatin and ezetimibe?

1 recruiting trial across 3 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.